Co-Diagnostics CODX
NASDAQ CODX
$0.55 -0.02 (-3.51%)
As of: Oct 23, 2026 · 3:06 PM EDT

Co-Diagnostics (CODX) Gross Profit (2017 - 2026)

Updated

Co-Diagnostics' Gross Profit was $120,828 in Q2 2026, down 7.6% from $130,804 a year earlier.

Analysis

Co-Diagnostics (CODX) Gross Profit (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Co-Diagnostics' Gross Profit was $492,253 through Jun 30, 2026, up 23.8% year-over-year; for FY2025, it was $400,112, down 86.3% from FY2024.

  • Gross Profit shows a five-year compound annual growth rate of -63.0% (FY2020 to FY2025).
  • In earlier years, Gross Profit was $2.92 million in FY2024 (+11.0%), $2.63 million in FY2023 (-90.9%), $28.74 million in FY2022 (-66.7%) and $86.31 million in FY2021 (+48.9%).
  • Quarterly Gross Profit has moved between -$261,289 (Q2 2023) and $26.79 million (Q3 2021) over five years.
  • The best year-over-year quarter for Gross Profit over five years was Q1 2024 (growth of 134.0%); the worst was Q1 2023 (a decline of 99.5%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Co-Diagnostics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CODX&period=max&api_key=YOUR_API_KEY